EGF Theramed Health (FRA:AUH) Debt-to-EBITDA : (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is EGF Theramed Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

EGF Theramed Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €1.03 Mil. EGF Theramed Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €0.00 Mil. EGF Theramed Health's annualized EBITDA for the quarter that ended in Mar. 2026 was €-0.21 Mil. EGF Theramed Health's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was -4.94.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for EGF Theramed Health's Debt-to-EBITDA or its related term are showing as below:

FRA:AUH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -16.45   Med: -1.93   Max: -0.07
Current: -16.45

During the past 11 years, the highest Debt-to-EBITDA Ratio of EGF Theramed Health was -0.07. The lowest was -16.45. And the median was -1.93.

FRA:AUH's Debt-to-EBITDA is ranked worse than
100% of 482 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs FRA:AUH: -16.45

EGF Theramed Health  (FRA:AUH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


EGF Theramed Health Debt-to-EBITDA Related Terms


EGF Theramed Health Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for EGF Theramed Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EGF Theramed Health Debt-to-EBITDA Chart

EGF Theramed Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EGF Theramed Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:AUH vs VEEV, BTSG, TEM: Debt-to-EBITDA Comparison

For the Health Information Services subindustry, EGF Theramed Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EGF Theramed Health Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EGF Theramed Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where EGF Theramed Health's Debt-to-EBITDA falls into.



EGF Theramed Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

EGF Theramed Health's Debt-to-EBITDA for the fiscal year that ended in Jun. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.94217065288305 + 0) / -1.5374890111207
=-0.61

EGF Theramed Health's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.0347574214418 + 0) / -0.2094019551543
=-4.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.


EGF Theramed Health Business Description

Other Exchanges EVAHF:USATMED:Canada
Address 609 Granville Street, Suite 1600, P.O. Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. It explores many other medical areas including weight loss, skincare and heart disease.